- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Survey of the Period of Tapering of a Strong Opioid Analgesic for Oral Mucositis Resulting from Concomitant Chemoradiotherapy for Head and Neck Cancer after the End of Treatment
-
- Tsuno Takehiko
- Department of Pharmacy, Yokohama City University Medical Center
-
- Tokumaru Jumpei
- Department of Pharmacy, Yokohama City University Medical Center
-
- Kojima Masanori
- Department of Pharmacy, Yokohama City University Medical Center
-
- Kitani Yousuke
- Department of Otolaryngology, Yokohama City University Medical Center
-
- Hashimoto Shinya
- Department of Pharmacy, Yokohama City University Medical Center
Bibliographic Information
- Other Title
-
- 頭頸部癌同時化学放射線療法による口腔咽頭粘膜炎に対する強オピオイド鎮痛薬の漸減期間に関する後方視的研究
Search this article
Description
<p>Severe pain from mucositis resulting from concomitant chemoradiotherapy (CCRT) is commonly treated with opioid analgesics. However, the period of use of opioid analgesics differs among individuals. We performed a retrospective cohort study of 46 patients who were treated with long-term opioid analgesics after CCRT for head and neck cancer. Among these patients, opioid analgesics were used for a median of 30 days. A comparative study was conducted between patients with long-term use of strong opioid analgesic drugs and those with short-term use. A significantly prolonged use of opioid analgesic agent was associated with cetuximab use (TPF vs. S-1 vs. Cmab, 35.0 vs. 44.1 vs. 180.7, p≤0.001). There were no psychiatric symptoms such as dependence and delirium. When patient background and chemotherapy selection are known, the possibility of severe oropharyngeal mucositis and the potential need for long-term opioid analgesics can be evaluated. Consideration of reduction or discontinuation according to pain after the end of treatment is important. </p>
Journal
-
- Palliative Care Research
-
Palliative Care Research 13 (4), 305-311, 2018
Japanese Society for Palliative Medicine
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282763058498944
-
- NII Article ID
- 130007495664
-
- ISSN
- 18805302
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed